Stock market anomaly | COVID-19 cases in some countries are on the rise, Moderna (MRNA.US) surged more than 10%

According to the Wisdom Finance APP, on Tuesday, the stock price of Moderna (MRNA.US) surged, as of the time of writing, the stock rose by more than 10%, to $29.265. The vaccine sector collectively rose, with Novavax Pharmaceuticals (NVAX.US) up more than 2%, to $7.92; Pfizer (PFE.US) rose 2%, to $23.46. In terms of news, according to the World Health Organization, the recent COVID-19 epidemic in Western Africa, Central America and the Caribbean, Eastern Europe, Southwest Europe and parts of Western Asia is on the rise.